RECENT WORK ON CONTROLLED DRUG DELIVERY SYSTEM

1. C. John, and C. Morten. The science of dosage form
design, Aulton modified release Peroral dosage
forms, Churchill livingstone, 2002, pp. 290-300.
2. D. M. Brahmankar, and S. B. Jaiswal.
Biopharmaceutics and Pharmacokinetics, Vallabh
Prakashan, 2009, pp. 399-401.
3. V. H. Lee. Controlled drug delivery fundamentals
and application, Influence of drug properties on
design, Marcel Decker, 1987, pp. 16-25.
4. S. K. P. Kumar, D. Bhownik, A. Dutta, and S. Paswan.
Recent trends in scope and opportunities of control
release oral drug delivery system, C. R. In. Pharm.
Sci. 2012.
5. N. Ali, R. Shaista, P. Patel, and A. A. Kofi. The Role of
oral controlled release matrix tablets in drug
delivery system, Bioimpacts 2(4): 175-187 (2012).
6. K. Modi, M. Modi, D. Mishra, M. Panchal, U.
Sorathiya, and P. Shelat. Oral controlled release
drug delivery system: An overview, I. R. J. Pharm
4(3): 70-76 (2013).
7. N. Ahuja, V. Kumar, and P. Rathee. Osmotic
controlled release oral delivery system: an
Avinash et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
707 | P a g e w w w . a r p b . i n f o
advanced oral delivery form, The Pharm. Inno 1(7):
116-124 (2012).
8. B. S. Rao, N. R. Kumar, K. Madhuri, P. S. Narayan, and
K. V. R. Murthy. Osmotic drug delivery system, E.
Pharma 44(521): 21-28 (2001).
9. R. K. Verma, D. M. Krishna, and S. Garg. Formulation
aspects in the development of osmotically
controlled oral drug delivery system, J. Con. Rel 79:
7-27 (2002).
10. G. Santus and R. W. Baker. Osmotic drug delivery: a
review of the patent literature, J. Con. Rel 35: 1-21
(1995).
11. Q. C. Hewei, Z. Chunli, W. Meng, J. Jhu, Z. Qiang, W.
Guangi, and Y. Lifang. Controlled release of
Metformin hydrochloride and Repaglinide from 2
sandwiched osmotic pump tablet, I. Jour. Pharma 1-
10 (2014).
12. P. Motugatla, E. Bhavya, and V. Gunasekharan.
Design and evaluation of osmotically controlled
drug delivery system of antihypertensive drug
Losartan potassium, W. J. P. Pharma. Sci 2(6): 6753-
6768 (2013).
13. G. Ramana, O. Sravathi, G. Sahithi, S. V. Naga, and G.
Priyanka. Formulation and evaluation of controlled
release hydrophilic matrices of Ambroxol
hydrochloride by melt granulation techniques, A. E.
J. Sci. Res 7(4): 150-159 (2012).
14. T. V. Rao, G. B. K. Kumar, M. G. Ahmed, and V. Joshi.
Development and evaluation of chitosan based oral
controlled matrix tablets of Losartan potassium, I. J.
Pharma. Inves 2(3): 157-161 (2012).
15. R. L. C. Sasidhar, S. Vidyadhara, N. R. Krishna, and R.
Nagaraju. Design and evaluation of Losartan
potassium matrix tablets with natural and synthetic
polymer, I. J. Pharma. Sci. Res 3(3): 928-933 (2012).
16. N. R. Shamma, E. B. Basalious, and R. A. Shoukri.
Development and optimization of a multiple unit
controlled release formulation of a freely water
soluble drug for once daily administration, I. J.
Pharma 405: 102-112 (2011).
17. R. V. Muthumanikandar, S. Edavalath, J. H. Robert, R.
Mukherjee, and T. V. Aneesh. Development and in
vitro evaluation of buccoadhesive tablet of Losartan
potassium, I. J. Drug Del 3: 465-471 (2011).
18. S. T. Prajapati, A. N. Patel, and C. N. Patel.
Formulation and evaluation of controlled release
tablet of Zolpidem tartrate by melt granulation
technique, I. S. R. Net. Pharmac 1-8 (2011).
19. H. Doddayya, S. S. Patil, A. Kaledhele, R. H. Udupi, S.
R. Reddy, and P. Kumar. Effect of gum rosin and
ethyl cellulose on in vitro release of Venlafaxine
hydrochloride from hydrophilic matrix tablets, I. J.
Pharma. Bio. Arch 2(3): 980-988 (2011).
20. M. Azharuddin, K. Kamath, T. Panneerselvam, S. S.
Pillai, and A. R. Shabaraya. Formulation and
evaluation of controlled release matrix tablets of
antihypertensive drug using natural and synthetic
hydrophilic polymers, R. Biotech 2(4): 26-32
(2011).
21. D. B. Raju, S. K. John, and M. M. Varma. Formulation
and evaluation of Losartan potassium matrix tablets
for oral controlled release, J. C. Pharma. Res 2(2):
130-135 (2010).
22. J. Emami, T. Mona, and A. Fatmeh. Preparation and
in vitro evaluation of sustained release matrix tablet
of Flutamide using synthetic and naturally occuring
polymers, I. J. Pharma. Res 7(4): 247-257 (2008).
23. S. Ganesh, M. Radhakrishnan, M. Ravi, B.
Prasannakumar and J. Kalyani. In vitro evaluation of
the effect of combination of hydrophilic and
hydrophobic polymers on controlled release
Zidovudine matrix tablets, I. J. Pharma. Sci 70(4):
461-465 (2008).
24. J. Shahla and F. Reza. Development of controlled
release low dose class II drug-Glipizide, I. J. Pharma
312: 24-32 (2006).
25. H. K. Raslan, and H. Maswadeh. In vitro dissolution
kinetic study of Theophylline from mixed controlled
release matrix tablets containing
hydroxypropylmethyl cellulose and glyceryl
behenate, I. J Pharma 68(3): 308-312 (2006).
26. N. U. Rahman, K. H. Yuen, Y. T. F. Tan and J. W.
Wong. Formulation and evaluation of controlled
release Diltiazem pellets using eudragit NE40, A.
Pharma. Turci 47: 199-207 (2005).
27. C. W. Vendruscolo, I. F. Andreazza, J. L. M. S. Ganter,
C. Ferrero, and T. M. B. Bresolin. Xanthan and
galactomannan (from M. scabrella) matrix tablets
for oral controlled delivery of Theophylline, I. J.
Pharma 296: 1-11 (2005).
28. D. Prabhakaran, P. Singh, P. Kanaujia, and S. P. Vyas.
Effect of hydrophilic polymers on the release of
Diltiazem hydrochloride from elementary osmotic
pumps, I. J. Pharma 259: 173-179 (2003).
29. A. B. Silvina, C. L. Maria, and J. S. Claudio. In-vitro
studies of Diclofenac sodium controlled release
from biopolymer hydrophilic matrices, J. Pharma.
Sci 5(3): 213-219 (2002).
30. S. Takka, S. Rajbhandari and A. Sakr. Effect of
anionic polymers on the release of propranolol
hydrochloride from matrix tablets, E. J. Pharma.
Biopharma 52: 75-82 (2001).
Avinash et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
708 | P a g e w w w . a r p b . i n f o
31. J. S. Christopher, R. B. William and L. Bruno.
Controlled release solid dosage form, W. O. Patent
WO2013169977, 2013.
32. J. Qingwie, Y. Weifeng, L. Quanzhi, Y. Wembin and Z
Junli. Osmotic pump controlled release tablet and
preparation method thereof, E. P. Patent
EP2478919, 2012.
33. G. Young, Z. Chunlin, Y. Qingmin, W. Jingyi, Z.
Xiaoquing, L. Gan and Z. XinXin. Pliperidone double
layered osmotic pump controlled release tablet and
preparation method thereof, U.S. Patent
US20120301547 A1, 2012.
34. S. K. Kulkarni, R. Kulkarni, P. Jadhav and A. Tiwari.
Controlled release pharmaceutical composition of
Milnacipran, U.S. Patent US20120128772 A1, 2012
35. G. A Sereno, B. D. Loeches, F. M. R. Varas, C. M. E. Del
and M. J. M. Rizo. A Pharmaceutical controlled
release composition of Losartan, E. P. Patent
EP2392318 A1, 2011.
36. C. Umit, T. Ali and P.A. Nur. Controlled release tablet
formulation of Pregabalin, E.P. Patent EP2389934
A1, 2011.
37. B. J. Lee, Y. W. Choi, B. G. Min and S. H. An.
Aceclofenac containing controlled release oral drug
preparations and their manufacturing process, E.P.
Patent EP2393486 A1, 2011.
38. P. Nilobon, X. X. Cheng, U. Lodin, C. M. Chen, A.
Nangia and D. Tian. Controlled release sodium
valporate formulation, U.S. Patent US7713550 B2,
2010.
39. T. Nghiem and G. Jackson. Controlled release
formulation using intelligent polymer, W.O. Patent
WO2010015567 A2, 2010.
40. N. B. Dharmadhikari and Y. R. Zala. Oral controlled
release tablet, E.P. Patent EP2242485 A2, 2010.
41. S. P. Pilgaonkar, M. T. Rustomjee, S. A. Gandhi, A.
Kelkar and P. Bagde. Controlled release formulation,
E.P. Patent EP1942875, 2008.
42. D. John, K. L. Cuming, S. Y. E. Hou and G. M. Gusler.
Method of treatment using a gastric retained
Losartan dosage, U.S. Patent US7413751 B2, 2008.
43. G. J. Young, S. J. Sung, W. K. Jin, W. K. Sung, S. K. Ja
and W. S. Jae. Controlled release pharmaceutical
composition containing thiazides and angiotensin II
receptor blockers, W.O. Patent WO2008054121 A1,
2008.
44. F. Vanderbist, P. Baudier, A. Deboeck, K. Amighi and
J. Goole. Controlled release floating dosage form,
W.O. Patent WO2007106960 A1, 2007.
45. J. K. Mandal, N. P. Pandya, S. A. Pillai and K. B.
Maheshwari. Controlled release formulation
comprising antiepileptic drug, W.O. Patent
WO2007122635 A2, 2007.
46. C. Xiu Xiu and C. Edward. Controlled release
metformin composition, U.S. Patent
US20060034922 A1, 2006.
47. P. C. Gary and S. H. Paul. Oxytocin controlled release
formulation and methods of using same, E.P. Patent
EP1605894 A2, 2005.
48. M. F. Befumo, J. Faour and J. A. Vergez. Osmotic
controlled release device containing Zafirlukast and
H1- antagonist, W.O. Patent WO2004087095 A2,
2004.
49. M. Kumar, R. S. Raghuvanshi and A. Rampal.
Controlled release formulation of Clarithromycin or
Tinidazole, W.O.Patent WO2003017981 A1, 2003.
50. M. Chawla, R. S. Raghuvanshi and A. Rampal.
Controlled release tablet of Metformin, W.O. Patent
WO2003039527 A1, 2003.
51. Q. Yihong, J. D. Bollinger, S. Dutta, H. S. Cheskin, K. R.
Engh, R. P. Poska and K. W. Sommeeville. Controlled
release formulation of Divalprox sodium, W.O.
Patent WO2002051401, 2002.
52. E. King and R. J. Macrae. Controlled release
pharmaceutical formulation containing a Cgmp PDE
5 inhibitor, W.O. Patent WO2000024383, 2000.
53. A. M. Mehta. Controlled release Nifedipine, U.S.
Patent US5871776A, 1999.
54. C. Chihming, X. X. Cheng and S. Jan. Diltiazem
controlled release formulation and method of
manufacture, U.S. Patent US6524620 B2, 1998.
55. C. Chihming and J. Deryang. Controlled release
formulation for water soluble drug in which a
passageway is formed in situ, U.S. Patent
US5558879 A, 1996.
56. C. Chihming and S. L. C. Charles. Controlled release
hydrogel formulation, U.S. Patent US5419917 A,
1995.
57. A. R. Baichwal and J. N. Staniforth. Controlled
release Verapamil tablet, U.S. Patent US5169639,
1992.
58. T. C. George. Controlled release formulation, E.P.
Patent EP0484106 A1, 1992.
59. M. T. Decrosta, N. B. Jain and E. M. Rudnic.
Controlled released formulation, U.S. Patent
US4666705 A, 1987.
60. S. Ummadi, B. Shravani, N. G. Raghavendra, S. M.
Reddy, and B. S. Nayak. Overview on controlled
release dosage form, I. J. Pharma. Sci 3(4): 250-269
(2013).
61. R. W. Korsemeyer, N. A. Reppas, and T. J. Roseman.
Macromolecular and modeling aspects of swelling
Avinash et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
709 | P a g e w w w . a r p b . i n f o
controlled systems, Controlled release delivery
system, Newyork, Marcel dekker, 1987, pp. 77.
62. C. V. S. Subrahmanyam. Text book of Physical
Pharmaceutics, Vallabh prakashan Delhi, 2003, pp.
180-234.